Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jill Slansky

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cancer Vaccines
14
2021
173
2.800
Why?
Receptors, Antigen, T-Cell
15
2023
720
2.500
Why?
CD8-Positive T-Lymphocytes
19
2024
917
2.430
Why?
Antigens, Neoplasm
13
2023
322
1.970
Why?
Neoplasms
13
2023
2666
1.930
Why?
T-Lymphocytes
14
2023
1999
1.880
Why?
Lymphocytes, Tumor-Infiltrating
5
2023
210
1.690
Why?
Vaccines, Subunit
4
2013
49
1.170
Why?
T-Lymphocytes, Cytotoxic
7
2022
173
0.970
Why?
Peptides
8
2023
986
0.960
Why?
Granzymes
2
2024
49
0.960
Why?
Epitopes, T-Lymphocyte
6
2012
187
0.930
Why?
Mice, Inbred BALB C
18
2021
1271
0.760
Why?
Leukemia
1
2024
238
0.740
Why?
Immunotherapy
8
2021
647
0.730
Why?
Lymphocyte Activation
11
2019
1150
0.710
Why?
Tumor Escape
3
2019
42
0.700
Why?
Baculoviridae
3
2009
44
0.660
Why?
Antigen Presentation
6
2018
216
0.650
Why?
Neoplasms, Experimental
2
2021
176
0.650
Why?
Tumor Microenvironment
7
2025
682
0.640
Why?
Immunogenetic Phenomena
1
2019
7
0.620
Why?
Immunomodulation
1
2020
98
0.620
Why?
Peptide Library
4
2013
88
0.620
Why?
Insecta
3
2009
64
0.600
Why?
Epitopes
2
2020
481
0.590
Why?
Histocompatibility Antigens Class I
6
2019
203
0.580
Why?
Major Histocompatibility Complex
4
2008
231
0.570
Why?
Animals
47
2025
37011
0.570
Why?
H-2 Antigens
5
2008
115
0.560
Why?
Mice
34
2025
17843
0.540
Why?
Alternative Splicing
1
2019
227
0.530
Why?
Gene Expression Regulation, Neoplastic
4
2019
1402
0.490
Why?
Autoimmunity
2
2020
907
0.480
Why?
Neoplasm Proteins
2
2018
433
0.450
Why?
Immune Tolerance
3
2025
362
0.450
Why?
Colorectal Neoplasms
5
2019
799
0.450
Why?
Vaccines
2
2010
411
0.450
Why?
Up-Regulation
3
2019
846
0.440
Why?
Antigens
3
2019
358
0.440
Why?
Breast Neoplasms
4
2025
2249
0.430
Why?
Cytotoxicity, Immunologic
6
2024
225
0.430
Why?
CD4-Positive T-Lymphocytes
3
2019
1092
0.400
Why?
Colonic Neoplasms
3
2012
258
0.400
Why?
Allergy and Immunology
1
2013
43
0.390
Why?
Complementarity Determining Regions
1
2012
51
0.380
Why?
Antigenic Variation
1
2011
10
0.370
Why?
B-Lymphocytes
1
2017
847
0.370
Why?
Moloney murine leukemia virus
1
2011
13
0.370
Why?
Viral Envelope Proteins
1
2011
84
0.350
Why?
B7-H1 Antigen
2
2025
218
0.330
Why?
Cell Cycle Proteins
6
1997
614
0.330
Why?
Carrier Proteins
6
1997
770
0.320
Why?
Histocompatibility Antigens
2
2020
107
0.320
Why?
DNA-Binding Proteins
9
2018
1507
0.300
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1079
0.300
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2022
337
0.290
Why?
Mice, Transgenic
6
2023
2182
0.290
Why?
Autoimmune Diseases
1
2012
459
0.280
Why?
Tetrahydrofolate Dehydrogenase
4
1997
23
0.280
Why?
Inflammation
4
2020
2837
0.270
Why?
Cross Reactions
2
2020
133
0.260
Why?
Vaccination
3
2010
1398
0.250
Why?
Liver Neoplasms
4
2020
786
0.250
Why?
Lung Neoplasms
2
2017
2494
0.240
Why?
Triple Negative Breast Neoplasms
2
2019
202
0.240
Why?
Flow Cytometry
6
2016
1185
0.230
Why?
Semaphorins
1
2025
32
0.230
Why?
Histocompatibility Antigens Class II
2
2003
368
0.230
Why?
Cell Line, Tumor
10
2025
3420
0.230
Why?
Antigens, CD
3
2025
524
0.220
Why?
Humans
36
2025
137514
0.220
Why?
Mammary Glands, Animal
1
2025
129
0.220
Why?
Disease Models, Animal
3
2021
4295
0.220
Why?
Graft Rejection
2
2007
623
0.220
Why?
Listeria monocytogenes
3
2011
126
0.200
Why?
Lymphocyte Count
4
2017
150
0.200
Why?
Models, Biological
1
2010
1775
0.200
Why?
Amino Acid Substitution
2
2020
309
0.190
Why?
Transcription Factors
6
1997
1717
0.190
Why?
Female
23
2025
73162
0.180
Why?
Aging
2
2011
1866
0.180
Why?
Base Sequence
7
2016
2180
0.180
Why?
Histocompatibility Antigen H-2D
4
2022
21
0.180
Why?
Dendritic Cells
3
2014
488
0.180
Why?
Receptor-CD3 Complex, Antigen, T-Cell
1
2000
9
0.170
Why?
Heterografts
1
2021
139
0.170
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1695
0.170
Why?
Cytoreduction Surgical Procedures
1
2020
63
0.170
Why?
Immune System
1
2021
177
0.160
Why?
Programmed Cell Death 1 Receptor
3
2019
252
0.160
Why?
Chemokines, CXC
1
2019
70
0.160
Why?
Bcl-2-Like Protein 11
1
2019
38
0.160
Why?
Gene Editing
1
2020
82
0.160
Why?
Chemotherapy, Adjuvant
1
2020
392
0.160
Why?
Nanotechnology
1
2020
126
0.150
Why?
Gene Transfer Techniques
1
2020
169
0.150
Why?
CRISPR-Cas Systems
1
2020
123
0.150
Why?
Interleukin-12
1
2019
121
0.150
Why?
Oligopeptides
1
2000
273
0.150
Why?
Mice, Knockout
5
2021
3020
0.150
Why?
Calcineurin
1
2019
108
0.150
Why?
Tryptophan Oxygenase
1
2018
34
0.150
Why?
Autoantigens
1
2021
429
0.150
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
81
0.140
Why?
Genetic Therapy
1
2020
296
0.140
Why?
Disease Susceptibility
1
2020
344
0.140
Why?
Mutation
5
2020
3964
0.140
Why?
Neoadjuvant Therapy
1
2020
405
0.140
Why?
Promoter Regions, Genetic
5
1997
1255
0.140
Why?
Cell Line
2
2016
2852
0.140
Why?
Histone Deacetylase Inhibitors
1
2019
211
0.140
Why?
Immunodominant Epitopes
2
2010
28
0.130
Why?
Antigen-Presenting Cells
1
2017
156
0.130
Why?
Tryptophan
1
2018
183
0.130
Why?
Genetic Engineering
2
2009
92
0.130
Why?
Protein Tyrosine Phosphatases
1
2018
171
0.130
Why?
Transcriptional Activation
2
2018
379
0.130
Why?
Antineoplastic Agents, Immunological
1
2019
191
0.130
Why?
Sarcoidosis, Pulmonary
1
2017
83
0.130
Why?
Spodoptera
2
2021
40
0.130
Why?
Oligonucleotide Array Sequence Analysis
2
2016
765
0.130
Why?
Mononuclear Phagocyte System
1
2016
12
0.130
Why?
Emulsions
1
2016
54
0.130
Why?
Ligands
4
2018
665
0.130
Why?
Immunophenotyping
1
2017
321
0.130
Why?
High-Throughput Nucleotide Sequencing
2
2017
538
0.120
Why?
Lymph Nodes
2
2016
493
0.120
Why?
Gene Expression Regulation
4
2022
2615
0.120
Why?
Phagocytes
1
2016
100
0.120
Why?
Papillomavirus Infections
1
2019
331
0.120
Why?
Cell Separation
1
2016
320
0.120
Why?
Lung
3
2017
4066
0.120
Why?
T-Lymphocyte Subsets
4
2007
425
0.110
Why?
Gene Expression Regulation, Enzymologic
2
1993
285
0.110
Why?
Bronchoalveolar Lavage Fluid
1
2017
654
0.110
Why?
Retinoblastoma-Binding Protein 1
6
1997
22
0.110
Why?
Ovarian Neoplasms
1
2020
563
0.110
Why?
Interferon-gamma
5
2011
790
0.110
Why?
Polymerase Chain Reaction
2
2016
1061
0.110
Why?
E2F Transcription Factors
6
1997
60
0.110
Why?
Head and Neck Neoplasms
1
2019
617
0.110
Why?
Transcription Factor DP1
5
1997
21
0.100
Why?
Colorado
2
2013
4521
0.100
Why?
Gene Expression Profiling
2
2010
1770
0.100
Why?
Prognosis
2
2020
4031
0.100
Why?
Molecular Sequence Data
8
2006
2901
0.100
Why?
T-Lymphocytes, Regulatory
3
2012
392
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2012
849
0.090
Why?
Transcription, Genetic
3
1997
1458
0.090
Why?
Lymphoma, B-Cell
1
2012
107
0.090
Why?
Hemangiosarcoma
1
2010
22
0.090
Why?
Universities
1
2013
432
0.080
Why?
Research
1
2013
446
0.080
Why?
Carcinoma
1
2011
237
0.080
Why?
Genes, MHC Class I
1
2009
35
0.080
Why?
Down-Regulation
1
2011
658
0.080
Why?
Mice, Inbred C57BL
5
2019
5792
0.080
Why?
Neovascularization, Pathologic
1
2010
301
0.080
Why?
Cross-Priming
1
2008
18
0.070
Why?
CD11c Antigen
1
2008
41
0.070
Why?
E2F1 Transcription Factor
4
1997
64
0.070
Why?
Adjuvants, Immunologic
1
2009
226
0.070
Why?
Protein Conformation
2
2003
930
0.070
Why?
Xenograft Model Antitumor Assays
2
2021
868
0.070
Why?
Cell Culture Techniques
1
2009
363
0.060
Why?
Intramolecular Oxidoreductases
1
2006
68
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2021
614
0.060
Why?
Biomarkers
1
2017
4172
0.060
Why?
RNA, Messenger
2
1994
2838
0.060
Why?
Melanoma, Experimental
1
2006
113
0.060
Why?
Drug Design
1
2006
170
0.060
Why?
DNA Primers
1
2006
514
0.060
Why?
Aged, 80 and over
1
2017
7593
0.060
Why?
Male
8
2020
67718
0.060
Why?
Amino Acid Sequence
5
2018
2146
0.060
Why?
G1 Phase
2
1996
71
0.060
Why?
S Phase
2
1996
78
0.060
Why?
Antigens, Surface
2
2001
154
0.050
Why?
Clone Cells
2
2003
266
0.050
Why?
Mice, SCID
2
2021
367
0.050
Why?
Cells, Cultured
1
2011
4206
0.050
Why?
Liver Neoplasms, Experimental
1
2003
31
0.050
Why?
3T3 Cells
4
2003
163
0.050
Why?
Genes, erbB-2
1
2003
28
0.050
Why?
Mammary Neoplasms, Experimental
1
2003
68
0.050
Why?
Transplantation Chimera
1
2002
54
0.050
Why?
Germ Cells
1
2022
63
0.050
Why?
Molecular Conformation
1
2022
152
0.050
Why?
Middle Aged
3
2020
33355
0.050
Why?
Interleukin-2
1
2003
456
0.050
Why?
Transglutaminases
1
2022
156
0.050
Why?
Sf9 Cells
1
2021
9
0.050
Why?
Bone Marrow Cells
1
2002
313
0.050
Why?
Chimerism
1
2021
31
0.040
Why?
B7-1 Antigen
1
2001
58
0.040
Why?
Aged
2
2017
23798
0.040
Why?
Lymphocyte Subsets
1
2021
87
0.040
Why?
Lymphoid Tissue
1
2021
75
0.040
Why?
Immunoglobulins
1
2001
171
0.040
Why?
Surface Plasmon Resonance
1
2000
88
0.040
Why?
Dogs
2
2012
411
0.040
Why?
Recombinant Proteins
1
2003
1357
0.040
Why?
Alanine
1
2000
153
0.040
Why?
Mice, Inbred NOD
1
2021
601
0.040
Why?
Cyclophosphamide
2
2011
251
0.040
Why?
Paraparesis, Tropical Spastic
1
1998
3
0.040
Why?
Skin Neoplasms
1
2006
853
0.040
Why?
Gene Products, tax
1
1998
13
0.040
Why?
Models, Molecular
1
2003
1586
0.040
Why?
Gene Knockdown Techniques
1
2019
329
0.040
Why?
Lymphocytic Choriomeningitis
1
1998
14
0.040
Why?
Antibodies, Monoclonal
1
2025
1428
0.040
Why?
Receptors, Tumor Necrosis Factor, Member 25
1
2017
5
0.040
Why?
Kynurenine
1
2018
114
0.030
Why?
Combined Modality Therapy
1
2020
1241
0.030
Why?
Antigens, Viral
1
1998
180
0.030
Why?
Mice, Nude
1
2019
696
0.030
Why?
Drug Delivery Systems
1
2020
363
0.030
Why?
HLA-DRB1 Chains
1
2017
112
0.030
Why?
HLA Antigens
1
2018
237
0.030
Why?
High-Throughput Screening Assays
1
2018
159
0.030
Why?
Folic Acid Antagonists
1
1996
9
0.030
Why?
Sp1 Transcription Factor
1
1996
24
0.030
Why?
Enzyme Induction
1
1996
90
0.030
Why?
Survival Rate
1
2020
1980
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
1996
92
0.030
Why?
Gene Amplification
1
1996
109
0.030
Why?
Clinical Trials as Topic
1
2020
1047
0.030
Why?
Cadaver
1
2016
319
0.030
Why?
Integrin alpha Chains
1
2014
24
0.030
Why?
Interleukin-27
1
2014
13
0.030
Why?
Toll-Like Receptor 3
1
2014
28
0.030
Why?
Poly I-C
1
2014
63
0.030
Why?
Toll-Like Receptor 7
1
2014
39
0.030
Why?
CD11b Antigen
1
2014
62
0.030
Why?
Acute Disease
1
2017
1008
0.030
Why?
DNA
3
1997
1460
0.030
Why?
Cell Division
2
1993
795
0.030
Why?
DNA Replication
1
1996
242
0.030
Why?
Cell Cycle
2
1994
604
0.030
Why?
Nuclear Proteins
2
2001
710
0.030
Why?
Culture Media, Serum-Free
1
1993
48
0.030
Why?
Imidazoles
1
2014
244
0.030
Why?
Serum Response Factor
1
1993
33
0.030
Why?
Cloning, Molecular
3
2001
536
0.020
Why?
RNA Polymerase II
1
1996
324
0.020
Why?
Phenotype
1
2021
3205
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2003
152
0.020
Why?
Antineoplastic Agents
1
2003
2145
0.020
Why?
Membrane Glycoproteins
1
2014
501
0.020
Why?
Antigens, Differentiation
1
2011
83
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
73
0.020
Why?
Disease Progression
1
2019
2755
0.020
Why?
CTLA-4 Antigen
1
2011
99
0.020
Why?
Follow-Up Studies
1
2020
5139
0.020
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
16
0.020
Why?
Cytokines
1
2019
2095
0.020
Why?
Dimerization
2
2001
198
0.020
Why?
Proteomics
1
2018
1113
0.020
Why?
Statistics, Nonparametric
1
2011
434
0.020
Why?
Protein Biosynthesis
1
1993
434
0.020
Why?
Doxorubicin
1
2012
368
0.020
Why?
ras Proteins
1
2010
151
0.020
Why?
Analysis of Variance
1
2011
1324
0.020
Why?
Survival Analysis
1
2011
1320
0.020
Why?
DNA, Complementary
2
2001
269
0.020
Why?
Protein Binding
2
2006
2229
0.020
Why?
Vaccines, Attenuated
1
2007
131
0.020
Why?
Binding Sites
3
1997
1310
0.020
Why?
Injections, Intradermal
1
2006
13
0.020
Why?
Peptide Fragments
2
2003
708
0.020
Why?
Enterotoxins
1
2006
87
0.020
Why?
Neoplasm Transplantation
1
2006
256
0.020
Why?
Hepatitis
1
2006
48
0.020
Why?
Cell Adhesion
1
2006
467
0.010
Why?
Killer Cells, Natural
1
2007
446
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2003
41
0.010
Why?
Adult
2
2017
37821
0.010
Why?
Growth Inhibitors
1
2003
43
0.010
Why?
Vaccines, DNA
1
2003
32
0.010
Why?
Peptide Mapping
1
2003
64
0.010
Why?
Cell Line, Transformed
1
2003
145
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2002
50
0.010
Why?
Injections, Intravenous
1
2003
208
0.010
Why?
Mammary Neoplasms, Animal
1
2002
33
0.010
Why?
Drug Synergism
1
2003
379
0.010
Why?
Mice, Inbred DBA
1
2002
200
0.010
Why?
Adoptive Transfer
1
2003
224
0.010
Why?
Mice, Inbred Strains
1
2003
413
0.010
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2001
10
0.010
Why?
Transplantation Immunology
1
2001
34
0.010
Why?
Programmed Cell Death 1 Ligand 2 Protein
1
2001
15
0.010
Why?
Transplantation, Homologous
1
2002
416
0.010
Why?
CD28 Antigens
1
2001
53
0.010
Why?
Gene Library
1
2001
117
0.010
Why?
Tumor Cells, Cultured
1
2002
957
0.010
Why?
Sequence Homology, Amino Acid
1
2001
387
0.010
Why?
Graft vs Host Disease
1
2002
249
0.010
Why?
Apoptosis Regulatory Proteins
1
2001
188
0.010
Why?
Genetic Vectors
1
2001
322
0.010
Why?
In Vitro Techniques
1
2001
1108
0.010
Why?
Image Cytometry
1
1998
7
0.010
Why?
HTLV-I Infections
1
1998
24
0.010
Why?
Human T-lymphotropic virus 1
1
1998
28
0.010
Why?
HLA-A2 Antigen
1
1998
48
0.010
Why?
Recombinant Fusion Proteins
1
2001
665
0.010
Why?
Immunity, Active
1
1998
10
0.010
Why?
Protein-Tyrosine Kinases
1
2001
434
0.010
Why?
E2F5 Transcription Factor
1
1997
3
0.010
Why?
E2F4 Transcription Factor
1
1997
8
0.010
Why?
Immunologic Memory
1
1998
369
0.010
Why?
HeLa Cells
1
1997
640
0.010
Why?
Proteins
1
2001
1012
0.010
Why?
Rats
1
2003
5676
0.010
Why?
Models, Genetic
1
1997
607
0.010
Why?
Genes
1
1994
230
0.010
Why?
Chromosome Mapping
1
1994
523
0.010
Why?
Molecular Weight
1
1992
332
0.010
Why?
Mutagenesis, Site-Directed
1
1992
377
0.010
Why?
Transfection
1
1992
948
0.000
Why?
Signal Transduction
1
2001
5096
0.000
Why?
Slansky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)